3 recherche sur le tag 'CANCER DRUG THERAPY'   

Prospects for antisense nucleic acid therapy of cancer and AIDS / Eric Wickstrom

Public ISBD Titre : Prospects for antisense nucleic acid therapy of cancer and AIDS Type de document : texte imprimé Auteurs : Eric Wickstrom, Éditeur scientifique Editeur : New York : John Wiley & Sons Année de publication : 1991 Importance : xiv, 269 p. ISBN/ISSN/EAN : 978-0-471-56880-3 Langues : Anglais (eng) Tags : CANCER DRUG THERAPY  ANTISENSE NUCLEIC ACIDS-Therapeutic use  CANCER-Genetic aspects  AIDS-Genetic aspects Index. décimale : EQ -Equipe- Résumé : "This study is designed to inform clinical investigators and biomedical researchers of the range of possible applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. These new DNA and RNA agents are intended to stop the growth of cancerous cells or to halt the production of HIV infected cells. The book details the rapid progress of this new technology from its theoretical stage to its current position at the verge of experimental clinical applications with provocative discussions of the therapeutic implications of the basic research." Cote : LCC/K Num_Inv : 549 Prospects for antisense nucleic acid therapy of cancer and AIDS [texte imprimé] / Eric Wickstrom, Éditeur scientifique . - New York : John Wiley & Sons, 1991 . - xiv, 269 p. ISBN : 978-0-471-56880-3 Langues : Anglais (eng) Tags : CANCER DRUG THERAPY  ANTISENSE NUCLEIC ACIDS-Therapeutic use  CANCER-Genetic aspects  AIDS-Genetic aspects Index. décimale : EQ -Equipe- Résumé : "This study is designed to inform clinical investigators and biomedical researchers of the range of possible applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. These new DNA and RNA agents are intended to stop the growth of cancerous cells or to halt the production of HIV infected cells. The book details the rapid progress of this new technology from its theoretical stage to its current position at the verge of experimental clinical applications with provocative discussions of the therapeutic implications of the basic research." Cote : LCC/K Num_Inv : 549

Exemplaires(1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
549	LCC/K	Texte imprimé	Equipe	Livre	Equipe - Demande préalable Disponible

Cancer chemotherapy reports. Part 2, vol.4 n°2 : Structure antitumor activity relationships among quinone derivatives / John S. Driscoll

Public ISBD Titre : Cancer chemotherapy reports. Part 2, vol.4 n°2 : Structure antitumor activity relationships among quinone derivatives Type de document : texte imprimé Auteurs : John S. Driscoll ; George F. Hazard ; Harry B. Wood, Éditeur scientifique ; Abraham Goldin, Éditeur scientifique Editeur : Bethesda : National Institute of Health Année de publication : 1974 Importance : 363 p. Langues : Anglais (eng) Catégories : Biochimie Tags : CANCER DRUG THERAPY  QUINONES-Therapeutic use Index. décimale : B-F Résumé : "This report is part of a continuing effort by the National Cancer Institute (NCI) to summarize animal antitumor screening data for selected classes of compounds and to relate this activity to chemical structure. Nucleoside, folic acid, and methanesulfonate derivatives have been treated previously. Quinones play significant roles in many areas of chemistry and biochemistry and many derivatives have been synthesized for study. Because of their availability and the biologic properties known to be associated with the quinone structure, a large number of these compounds have been screened over the past 17 years in the NCI's Drug Research and Development program aimed at the discovery of leads to new classes of antitumor drugs. This report is a summary and an analysis of animal antitumor data for the quinone derivatives evaluated by the NCI. While general structure activity relationships and conclusions are drawn, more detailed analyses (both qualitative and quantitative) are possible. It is hoped that this review will be useful to investigators who are interested in further studies of antitumor agents in general and quinone derivatives in particular." Cote : B-F031 (SdS) Num_Inv : 2409 Cancer chemotherapy reports. Part 2, vol.4 n°2 : Structure antitumor activity relationships among quinone derivatives [texte imprimé] / John S. Driscoll ; George F. Hazard ; Harry B. Wood, Éditeur scientifique ; Abraham Goldin, Éditeur scientifique . - Bethesda : National Institute of Health, 1974 . - 363 p. Langues : Anglais (eng) Catégories : Biochimie Tags : CANCER DRUG THERAPY  QUINONES-Therapeutic use Index. décimale : B-F Résumé : "This report is part of a continuing effort by the National Cancer Institute (NCI) to summarize animal antitumor screening data for selected classes of compounds and to relate this activity to chemical structure. Nucleoside, folic acid, and methanesulfonate derivatives have been treated previously. Quinones play significant roles in many areas of chemistry and biochemistry and many derivatives have been synthesized for study. Because of their availability and the biologic properties known to be associated with the quinone structure, a large number of these compounds have been screened over the past 17 years in the NCI's Drug Research and Development program aimed at the discovery of leads to new classes of antitumor drugs. This report is a summary and an analysis of animal antitumor data for the quinone derivatives evaluated by the NCI. While general structure activity relationships and conclusions are drawn, more detailed analyses (both qualitative and quantitative) are possible. It is hoped that this review will be useful to investigators who are interested in further studies of antitumor agents in general and quinone derivatives in particular." Cote : B-F031 (SdS) Num_Inv : 2409

Exemplaires(1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
2409	B-F031	Texte imprimé	Bibliothèque	Livre	Disponible

Metal based anti-tumor drugs / Marcel Gielen

Public ISBD Titre : Metal based anti-tumor drugs Type de document : texte imprimé Auteurs : Marcel Gielen, Auteur Editeur : Freund Publishing House Année de publication : 1988 Importance : 301 p. Langues : Anglais (eng) Catégories : Biochimie Tags : CANCER DRUG THERAPY Index. décimale : B-F Cote : B-F013 Num_Inv : 444 Localisation : LCC (SdS) Metal based anti-tumor drugs [texte imprimé] / Marcel Gielen, Auteur . - Freund Publishing House, 1988 . - 301 p. Langues : Anglais (eng) Catégories : Biochimie Tags : CANCER DRUG THERAPY Index. décimale : B-F Cote : B-F013 Num_Inv : 444 Localisation : LCC (SdS)

Exemplaires(1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
444	B-F013	Texte imprimé	Bibliothèque	Livre	Disponible